@Article{Dobak2024,
journal="Polish Journal of Pathology",
issn="1233-9687",
volume="75",
number="3",
year="2024",
title="The role of the CLL-1 protein in disease monitoring  in patients diagnosed with acute myeloid leukaemia  and myelodysplastic syndrome",
abstract="The normal subpopulation of CD34+CD38 – haematopoietic stem cells does not express CLL-1; therefore, the assessment of the expression of this protein can be used for the diagnosis of minimal residual disease. The aim of this study was to evaluate, using multi-colour flow cytometry, the level of CLL-1 protein expression on CD34+CD38- myeloid niche cells in acute myeloid leukaemia (AML) and myelodysplastic syndromepatients at the time of diagnosis and during disease monitoring on the example  of 3 practical cases. The following conclusion was drawn: CD34+CD38-CLL-1+ cells in AML patients may serve as a biomarker to predict disease aggressiveness.",
author="Dobak, Ewa
and Jankowska-Szabłowska, Sylwia Romana
and Guzicka-Kazimierczak, Renata
and Poter, Paulina
and Urasińska, Elżbieta
and Karpińska-Łukaszewicz, Katarzyna",
pages="182--191",
doi="10.5114/pjp.2024.143228",
url="http://dx.doi.org/10.5114/pjp.2024.143228"
}